PDZD7 Polyclonal Antibody, PE-Cy5.5 Conjugated
Applications
Reactivity
Overview | |
Catalog # | bs-9042R-PE-Cy5.5 |
Product Name | PDZD7 Polyclonal Antibody, PE-Cy5.5 Conjugated |
Applications | WB |
Reactivity | Human, Mouse, Rat |
Specifications | |
Conjugation | PE-Cy5.5 |
Host | Rabbit |
Source | KLH conjugated synthetic peptide derived from human PDZD7 |
Immunogen Range | 121-220/517 |
Clonality | Polyclonal |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Gene ID | 79955 |
Synonyms | PDZ domain containing 7; PDZK7; RP11-108L7.9; EG435601; OTTMUSP00000044305; 9130207N01; OTTMUSP00000044304; PDZD7_HUMAN. |
Background | PDZK7, also known as PDZD7, is a 517 amino acid protein that contains two PDZ (DHR) domains. Encoded by a gene that maps to human chromosome 10q24.31, PDZK7 is conserved in dog, mouse and rat, and exists as three alternatively spliced isoforms. PDZK7 is known to interact with Harmonin, MASS1, USH1G and Usherin. Localizing to nucleus, PDZK7 is expressed in retinal pigment epithelium and inner ear. Biallelic inactivation of PDZK7 can cause non-syndromic hearing impairment and chromosomal aberrations, which are linked to non-syndromic sensorineural deafness. PDZK7 mutations are also linked to Usher syndrome, which is characterized by retinitis pigmentosa and sensorineural deafness, and Alzheimer disease. The gene that encodes PDZK7 maps to human chromosome 10q24.31. |
Application Dilution | |
WB | 1:300-5000 |